Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0301997 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Cara J Broshkevitch und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of North Carolina-Chapel Hill, Chapel Hill, NC, United States of America. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Vaccines. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Introduction
Women living with HIV experience heightened risk of cervical cancer, and over 50% of cases in Southern Africa are attributed to HIV co-infection. Cervical cancer interventions tailored by HIV status delivered with HIV antiretroviral therapy (ART) for treatment can decrease cancer incidence, but impact on HIV-related disparities remains understudied.
Methods
Using a dynamic model calibrated to KwaZulu-Natal, South Africa, we projected HIV prevalence, cervical cancer incidence, and proportion of cancer cases among women living with HIV between 2021–2071. Relative to the status quo of moderate intervention coverage, we modeled three additive scenarios: 1) ART scale-up only; 2) expanded human papillomavirus (HPV) vaccination, screening, and treatment; and 3) catch-up HPV vaccination and enhanced screening for women living with HIV.
Results
Under the status quo, HIV prevalence among women aged 15+ decreased from a median of 35% [Uncertainty Range (UR): 26–42%] in 2021 to 25% [19–34%] in 2071. The proportion of cervical cancer cases that were women living with HIV declined from 73% [63–86%] to 58% [47–74%], but incidence remained 4.3-fold [3.3–5.7] that of women without HIV. ART scale-up reduced HIV prevalence in 2071, but increased the incidence rate ratio to 5.2 [3.7–7.3]. Disparities remained after expanding cancer interventions for all women (incidence rate ratio: 4.8 [3.6–7.6]), while additional catch-up HPV vaccination and screening for women living with HIV decreased the incidence rate ratio to 2.7 [1.9–3.4] in 2071.
Conclusions
Tailored cervical cancer interventions for women living with HIV can counteract rising cancer incidence incurred by extended life expectancy on ART and reduce disparate cancer burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, University of North Carolina-Chapel Hill, Chapel Hill, NC, United States of America.
- Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, United States of America.
- Harvard Medical School, Boston, MA, United States of America.
- Department of Global Health, University of Washington, Seattle, WA, United States of America.
- Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
- Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, United States of America.
ORCID-Profile: Cara J Broshkevitch, Ruanne V Barnabas
Förderung
- NCI NIH HHS
- Division of Cancer Epidemiology and Genetics, National Cancer Institute
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Broshkevitch, C. J., Barnabas, R. V., Liu, G., Palanee-Phillips, T., & Rao, D. W. (2024). Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0301997
Vancouver
Broshkevitch CJ, Barnabas RV, Liu G, Palanee-Phillips T, Rao DW. Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis. PLOS ONE. 2024. doi:10.1371/journal.pone.0301997
BibTeX
@article{Broshkevitch2024,
author = {Broshkevitch, Cara J and Barnabas, Ruanne V and Liu, Gui and Palanee-Phillips, Thesla and Rao, Darcy White},
title = {Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0301997}
}
EUVIMED